Compare PAGS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAGS | XENE |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | Brazil | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.2B |
| IPO Year | 2017 | 2014 |
| Metric | PAGS | XENE |
|---|---|---|
| Price | $9.91 | $41.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $11.86 | ★ $53.70 |
| AVG Volume (30 Days) | ★ 4.0M | 815.1K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $14.75 | N/A |
| Revenue Next Year | $5.68 | $1,645.94 |
| P/E Ratio | $7.74 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.16 | $26.74 |
| 52 Week High | $12.32 | $46.99 |
| Indicator | PAGS | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 45.81 |
| Support Level | $9.32 | $39.56 |
| Resistance Level | $10.22 | $44.15 |
| Average True Range (ATR) | 0.52 | 1.89 |
| MACD | -0.11 | -0.13 |
| Stochastic Oscillator | 18.10 | 15.99 |
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.